American Express Co. (AXP) Falls 2.88% for January 28

Equities Staff  |

One of the S&P 500’s big losers for Thursday January 28 was American Express Co. (AXP). The company’s stock fell 2.88% to $52.95 on volume of 14.74 million shares.

The stock opened the day at 54.68 and traded between a low of $52.15 and a high of $54.76. The stock finished the day down $1.57 per share. American Express Co. has an average daily volume of 6.77 million and a total float of 984.25 million shares. The 50-day SMA for American Express Co. is $67.40 and its 200-day SMA is $74.42. The high for the stock over the last 52 weeks is $86.18 and the low is $54.14.

American Express Co is a payments, network and travel company, which offers credit payment card products and travel-related services to consumers and businesses.

American Express Co. is centered in New York, NY, and has 54,000 employees. Today’s trading day leaves the company with a market cap of $52.12 billion. The company has a P/S ratio of n/a, P/B ratio of 2.44, and a 8.7.

For a complete fundamental analysis analysis of American Express Co., check out’s Stock Valuation Analysis report for AXP. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor,; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…